Metronidazole–Flavonoid Derivatives as Anti‐Helicobacter pyloriAgents with Potent Inhibitory Activity against HPE‐Induced Interleukin‐8 Production by AGS Cells

Authors:

Abstract
Three series of metronidazole–flavonoid derivatives were generated and evaluated for antimicrobial activity againstH. pylori. Among these compounds, high anti‐H. pyloriactivities were observed in isoflavones derivatives4–7,19, and20but exhibited no inhibitory activity against other sorts of bacteria and fungi, for example,Streptococcus pneumoniae, Bacillus subtilis, Escherichia coli, Pseudomonas fluorescence, andAspergillus niger. Genistein derivative6with the potent activity (MIC=0.39 μg mL−1) was >50‐fold more than metronidazole, and comparable to the positive control amoxicillin. Additionally, compound6can significantly attenuate the increase in interleukin‐8 (IL‐8) levels in the AGS cells stimulated byH. pyloriwater extract (HPE) at concentrations of 15, 30, and 60 μmol L−1, which did not show any effects on the cell viability.

This publication has 25 references indexed in Scilit: